ShareHope Medicine Co Ltd (8403) - Cash Flow Conversion Efficiency
Based on the latest financial reports, ShareHope Medicine Co Ltd (8403) has a cash flow conversion efficiency ratio of 0.028x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$110.81 Million ≈ $3.49 Million USD) by net assets (NT$4.02 Billion ≈ $126.52 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
ShareHope Medicine Co Ltd - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how ShareHope Medicine Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read total liabilities of ShareHope Medicine Co Ltd for a breakdown of total debt and financial obligations.
ShareHope Medicine Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ShareHope Medicine Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Kabra Extrusion Technik Limited
NSE:KABRAEXTRU
|
-0.022x |
|
Gan Ltd
NASDAQ:GAN
|
-0.074x |
|
Raonsecure Co. Ltd
KQ:042510
|
-0.015x |
|
Avgol Industries 1953 Ltd
TA:AVGL
|
0.038x |
|
Kyobo With Special Purpose Acq
KQ:205100
|
0.014x |
|
Alithya Group Inc
NASDAQ:ALYAF
|
0.152x |
|
Evergreen Max Cash Capital Berhad
KLSE:0286
|
-0.151x |
|
Sucro Limited
V:SUGR
|
-0.053x |
Annual Cash Flow Conversion Efficiency for ShareHope Medicine Co Ltd (2017–2024)
The table below shows the annual cash flow conversion efficiency of ShareHope Medicine Co Ltd from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see 8403 market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | NT$3.98 Billion ≈ $125.43 Million |
NT$266.68 Million ≈ $8.40 Million |
0.067x | +3.04% |
| 2023-12-31 | NT$3.96 Billion ≈ $124.62 Million |
NT$257.13 Million ≈ $8.10 Million |
0.065x | -58.52% |
| 2022-12-31 | NT$4.10 Billion ≈ $129.14 Million |
NT$642.47 Million ≈ $20.24 Million |
0.157x | +69.02% |
| 2021-12-31 | NT$3.88 Billion ≈ $122.35 Million |
NT$360.10 Million ≈ $11.35 Million |
0.093x | -53.76% |
| 2020-12-31 | NT$3.58 Billion ≈ $112.76 Million |
NT$717.74 Million ≈ $22.61 Million |
0.201x | +7.75% |
| 2019-12-31 | NT$2.70 Billion ≈ $85.08 Million |
NT$502.62 Million ≈ $15.84 Million |
0.186x | +1306.12% |
| 2018-12-31 | NT$2.56 Billion ≈ $80.71 Million |
NT$33.91 Million ≈ $1.07 Million |
0.013x | -56.83% |
| 2017-12-31 | NT$2.05 Billion ≈ $64.49 Million |
NT$62.76 Million ≈ $1.98 Million |
0.031x | -- |
About ShareHope Medicine Co Ltd
ShareHope Medicine Co., Ltd. provides integrated medical services in Taiwan. It is involved in the health management and operation activities; human resource dispatch of professional medical staff; provision of medical, pharmaceutical, and health devices, as well as long-distance health care services; and rental of medical devices. ShareHope Medicine Co., Ltd. was founded in 2003 and is based in … Read more